glp-1 agonist history glp-1_analogs [TUSOM Trends in the Development of
Description
Renal protection by sodium-glucose cotransporter 2 inhibitors and its underlying mechanisms in diabetic kidney disease
Stopping Treatment: Weight regain often occurs after discontinuation, typically two-thirds of lost weight within a year
Dual inhibition of the renin-angiotensin system in high-risk diabetes and risk for stroke and other outcomes: results of the ONTARGET trial
once-daily administration of vehicle at 16:00 h, s.c
Part D is the drug coverage component of Medicare
June 2023
